Browsing: wegovy

Novo Nordisk cuts Wegovy and Ozempic direct-to-consumer prices to $349 per month across the United States, expanding access for uninsured patients.

Pfizer forecasts 2025 revenue of up to $64 billion and adjusted earnings growth, navigating cost challenges amid Medicare changes and advancing promising drug pipeline assets, including its weight-loss candidate.